Latest Clinical trials biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

Un estudio internacional abre la puerta a un nuevo tratamiento estándar para el cáncer de cabeza y cuello

by ICO - Institut Català d'Oncologia

9 months ago
cáncer de cabeza y cuello, inmunoterapia con nivolumab

La combinación de la inmunoterapia con nivolumab al tratamiento clásico de radioterapia y quimioterapia después de una cirugía, mejora la supervivencia libre de enfermedad y podría transformar la...

ORYZON strengthens patent portfolio for iadademstat with European grant decision covering combinations with PD1/PD-L1 inhibitors

by Oryzon Genomics

9 months ago
PD1 or PD-L1 inhibitors, Iadademstat, small cell lung cancer (SCLC), atezolizumab or durvalumab

Oryzon Genomics today announced that the European Patent Office (EPO) has issued a Decision to Grant for its patent application EP20712594.9, entitled “Combinations of iadademstat for cancer therapy...

Endotoxin-free proteins for high-precision research

by Abyntek

9 months ago
ProPure™, endotoxins

Abyntek distributes the products of Sino Biological, a leading biotechnology company that has raised the standard in recombinant protein production with its ProPure™ line, specifically designed for ...

Imprimen modelos tumorales en 3D con células reales de cáncer de mama para el ensayo de fármacos

by CIC biomaGUNE

9 months ago
tumores en 3D, cáncer de mama, organoides

Un grupo de CIC biomaGUNE fabrica modelos de tumores para entender cómo crecen y se comportan en distintas condiciones

A new guideline co-led by Vall d'Hebron proposes a change in the pharmacological approach to obesity based on improving health and reducing complications

by Vall d’Hebron

9 months ago
obesity

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

What Role is Precision Medicine Playing in Transforming Cancer Treatment, and How Are Developers Adapting?

by Tebubio

9 months ago
Precision Medicine, CRISPR and mRNA

Precision medicine is redefining oncology by moving away from “one-size-fits-all” treatments towards therapies tailored to the unique genetic and molecular profile of each patient.

TherVacB Project Begins Patient Trial to Advance Curative Strategy for Chronic Hepatitis B

by Fundació Clínic per a la Recerca Biomèdica

9 months ago
Chronic hepatitis B virus (HBV), TherVacB project

The TherVacB project (A Therapeutic Vaccine to Cure Hepatitis B), has now reached a major milestone with the launch of its clinical trial in patients. Building on over a decade of research, the projec...

AM-Pharma Completes Enrollment in Phase 2 Study of Ilofotase Alfa for Prevention of Cardiac Surgery-Associated Renal Damage

by Ysios Capital

9 months ago
Ilofotase Alfa, cardiac surgery-associated renal damage (CSA-RD).

AM-Pharma B.V. today announced that it has successfully completed enrollment of patients in its ongoing Phase 2 clinical trial evaluating ilofotase alfa for the prevention of cardiac surgery-associate...

Sant Pau Participates in an International Gene Therapy Trial for Wet Macular Degeneration

by Hospital de la Santa Creu i Sant Pau

9 months ago
age-related macular degeneration (AMD), ABBV-RGX-314

The Ophthalmology Department of Hospital de Sant Pau, together with the Ophthalmology Research Group of the Sant Pau Research Institute (IR Sant Pau), has recently participated in an international cli...

An international study questions the routine use of beta-blockers after a heart attack in patients with a residual ejection fraction greater than 50%

by Instituto de Investigación Marqués de Valdecilla

9 months ago
beta-blockers

The REBOOT trial concludes, published in “The New England Journal of Medicine”, with the participation of Dr. José María de la Torre Hernández, Head of Cardiology at Valdecilla Hospital

La AEMPS amplía el procedimiento de evaluación acelerada para ensayos de fases tempranas

by Sermes CRO

9 months ago
ensayos clínicos en fases tempranas

La Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) ha anunciado la ampliación de su procedimiento de evaluación acelerada para ensayos clínicos en fases tempranas, una medida que c...

A breakthrough opens the door to preventing aortic aneurysms without surgery

by Instituto de Investigación Marqués de Valdecilla

9 months ago
aortic aneurysms, hexosamine biosynthetic pathway

The study not only demonstrates the feasibility of new therapeutic targets but also opens the possibility of early diagnosis. The authors identified blood biomarkers related to the activation of this ...